{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:38:25Z","timestamp":1792787905085,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:00:00Z","timestamp":1791244800000},"content-version":"vor","delay-in-days":88,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Key Clinical Program of Peking University Third Hospital","award":["No. BYSYZD2021036"],"award-info":[{"award-number":["No. BYSYZD2021036"]}],"id":[{"id":"https:\/\/ror.org\/04wwqze12","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470774"],"award-info":[{"award-number":["82470774"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Clinical Cohort Construction Program of Peking University Third Hospital","award":["BYSYDL2023004"],"award-info":[{"award-number":["BYSYDL2023004"]}],"id":[{"id":"https:\/\/ror.org\/04wwqze12","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Bile acids (BAs) are now recognized as endocrine hormones involved in glucose and lipid metabolism regulation and inflammation control. Recent studies have also shown the association of BAs level in chronic kidney disease progression and hemodialysis patients\u2019 prognosis. However, their role in peritoneal dialysis (PD) is unknown. Therefore, based on a longitudinal cohort, this study aims to explore the relationship of BAs and all-cause mortality in PD patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective cohort study was conducted involving 517 PD patients. Serum BAs level prior to PD catheterization were collected. Restricted cubic spline (RCS) analysis with full adjustment was used to characterize the dose-response relationship between serum BAs and all-cause mortality. Cox proportional hazards regression models were performed to assess the independent association between BAs levels and all-cause mortality.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 517 patients were included. During a median follow-up of 3.65 (1.36, 5.46) years, death occurred in 210 of 517 (40.6%) patients. The relationship between BAs levels and the risk of all-cause mortality was fitted using multivariate RCS adjusted for clinical relevant factors showing that BAs levels were linearly associated with all-cause mortality (p for non-linearity\u2009=\u20090.589). Further Kaplan-Meier survival analysis revealed a significantly higher all-cause mortality risk in the high BAs group (log rank score 13.04,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Cox regression showed that elevated BAs levels were an independent risk factor for all-cause mortality in PD patients (HR\u2009=\u20091.056, 95% CI: 1.005\u20131.109,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.031) after adjusting for confounding factors.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Elevated pre-dialysis serum BAs levels are independently associated with increased all-cause mortality in PD patients. Serum BAs may represent a potential prognostic indicator, although further validation is required before clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-026-05187-3","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T08:35:34Z","timestamp":1783672534000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bile acids as a predictor for all-cause mortality in peritoneal dialysis patients: a retrospective cohort study"],"prefix":"10.1186","volume":"27","author":[{"given":"Siyuan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiong","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,10]]},"reference":[{"issue":"5","key":"5187_CR1","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1159\/000502145","volume":"44","author":"W Gu","year":"2019","unstructured":"Gu W, et al. Metabolic Syndrome and Mortality in Continuous Ambulatory Peritoneal Dialysis Patients: A 5-Year Prospective Cohort Study. Kidney Blood Press Res. 2019;44(5):1026\u201335.","journal-title":"Kidney Blood Press Res"},{"issue":"3","key":"5187_CR2","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/j.ajkd.2020.05.032","volume":"77","author":"Y Cho","year":"2021","unstructured":"Cho Y, et al. Peritoneal Dialysis Use and Practice Patterns: An International Survey Study. Am J Kidney Dis. 2021;77(3):315\u201325.","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"5187_CR3","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3747\/pdi.2013.00083","volume":"35","author":"Y Wen","year":"2015","unstructured":"Wen Y, et al. High glucose concentrations in peritoneal dialysate are associated with all-cause and cardiovascular disease mortality in continuous ambulatory peritoneal dialysis patients. Perit Dial Int. 2015;35(1):70\u20137.","journal-title":"Perit Dial Int"},{"issue":"1","key":"5187_CR4","doi-asserted-by":"publisher","first-page":"35283","DOI":"10.1038\/s41598-025-19171-8","volume":"15","author":"KM Hsu","year":"2025","unstructured":"Hsu KM, et al. Triglyceride-glucose index predicts the mortality risk among incident peritoneal dialysis patients in a cohort study. Sci Rep. 2025;15(1):35283.","journal-title":"Sci Rep"},{"key":"5187_CR5","doi-asserted-by":"publisher","first-page":"119864","DOI":"10.1016\/j.cca.2024.119864","volume":"562","author":"A Ziegler","year":"2024","unstructured":"Ziegler A, et al. Differences in bile acid profiles between cholestatic diseases - Development of a high throughput assay for dried bloodspots. Clin Chim Acta. 2024;562:119864.","journal-title":"Clin Chim Acta"},{"issue":"1","key":"5187_CR6","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s12902-017-0211-5","volume":"17","author":"X Yan","year":"2017","unstructured":"Yan X, et al. The relationship between bile acid concentration, glucagon-like-peptide 1, fibroblast growth factor 15 and bile acid receptors in rats during progression of glucose intolerance. BMC Endocr Disord. 2017;17(1):60.","journal-title":"BMC Endocr Disord"},{"issue":"1","key":"5187_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1186\/s40168-023-01709-5","volume":"11","author":"H Xu","year":"2023","unstructured":"Xu H, et al. Gut microbiota-bile acid crosstalk regulates murine lipid metabolism via the intestinal FXR-FGF19 axis in diet-induced humanized dyslipidemia. Microbiome. 2023;11(1):262.","journal-title":"Microbiome"},{"issue":"3","key":"5187_CR8","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","volume":"10","author":"C Thomas","year":"2009","unstructured":"Thomas C, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. Cell Metab. 2009;10(3):167\u201377.","journal-title":"Cell Metab"},{"issue":"1","key":"5187_CR9","doi-asserted-by":"publisher","first-page":"2226221","DOI":"10.1080\/0886022X.2023.2226221","volume":"45","author":"B Li","year":"2023","unstructured":"Li B, et al. The relationship between bile acids levels and the prognosis of patients with diabetes on maintenance hemodialysis: a retrospective study. Ren Fail. 2023;45(1):2226221.","journal-title":"Ren Fail"},{"key":"5187_CR10","doi-asserted-by":"publisher","first-page":"117826","DOI":"10.1016\/j.cca.2024.117826","volume":"555","author":"T Yang","year":"2024","unstructured":"Yang T, et al. A landscape of metabolic variation among clinical outcomes of peritoneal dialysis in end-stage renal disease. Clin Chim Acta. 2024;555:117826.","journal-title":"Clin Chim Acta"},{"key":"5187_CR11","doi-asserted-by":"publisher","first-page":"1026995","DOI":"10.3389\/fendo.2022.1026995","volume":"13","author":"X Xiao","year":"2022","unstructured":"Xiao X, et al. Lower bile acids as an independent risk factor for renal outcomes in patients with type 2 diabetes mellitus and biopsy-proven diabetic kidney disease. Front Endocrinol (Lausanne). 2022;13:1026995.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"5187_CR12","doi-asserted-by":"crossref","unstructured":"Levey AS, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150(9):604-612.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"5187_CR13","doi-asserted-by":"publisher","first-page":"1416506","DOI":"10.3389\/fendo.2025.1416506","volume":"16","author":"L Huang","year":"2025","unstructured":"Huang L, et al. Nonlinear association between glycated hemoglobin levels and mortality in elderly patients with non-diabetic chronic kidney disease: a national health and nutrition examination survey analysis. Front Endocrinol (Lausanne). 2025;16:1416506.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"5187_CR14","first-page":"1723","volume":"42","author":"Y Liu","year":"2018","unstructured":"Liu Y, et al. Farnesoid X receptor agonist decreases lipid accumulation by promoting hepatic fatty acid oxidation in db\/db mice. Int J Mol Med. 2018;42(3):1723\u201331.","journal-title":"Int J Mol Med"},{"issue":"8","key":"5187_CR15","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","volume":"33","author":"BL Clifford","year":"2021","unstructured":"Clifford BL, et al. FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption. Cell Metab. 2021;33(8):1671\u2013e16844.","journal-title":"Cell Metab"},{"key":"5187_CR16","doi-asserted-by":"crossref","unstructured":"Tschuck J et al. Farnesoid X receptor activation by bile acids suppresses lipid peroxidation and ferroptosis. Nat Commun. 2023; 14(1).","DOI":"10.1038\/s41467-023-42702-8"},{"issue":"21","key":"5187_CR17","doi-asserted-by":"publisher","first-page":"3280","DOI":"10.3748\/wjg.v29.i21.3280","volume":"29","author":"M Wei","year":"2023","unstructured":"Wei M, et al. Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy. World J Gastroenterol. 2023;29(21):3280\u201391.","journal-title":"World J Gastroenterol"},{"key":"5187_CR18","doi-asserted-by":"publisher","first-page":"p713149","DOI":"10.3389\/fphar.2021.713149","volume":"12","author":"A Stefela","year":"2021","unstructured":"Stefela A, et al. (E)-7-Ethylidene-lithocholic Acid (7-ELCA) Is a Potent Dual Farnesoid X Receptor (FXR) Antagonist and GPBAR1 Agonist Inhibiting FXR-Induced Gene Expression in Hepatocytes and Stimulating Glucagon-like Peptide-1 Secretion From Enteroendocrine Cells. Front Pharmacol. 2021;12:p713149.","journal-title":"Front Pharmacol"},{"issue":"1","key":"5187_CR19","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13098-023-00989-z","volume":"15","author":"XP Bai","year":"2023","unstructured":"Bai XP, et al. Influence of ursodeoxycholic acid on blood glucose, insulin and GLP-1 in rats with liver fibrosis induced by bile duct ligation. Diabetol Metab Syndr. 2023;15(1):18.","journal-title":"Diabetol Metab Syndr"},{"key":"5187_CR20","doi-asserted-by":"crossref","unstructured":"Dong H et al. Imbalance of bile acids metabolism mediated by gut microbiota contributed to metabolic disorders in diabetic model mice. Biology (Basel). 2025;14(3):291.","DOI":"10.3390\/biology14030291"},{"issue":"1","key":"5187_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41522-024-00566-w","volume":"10","author":"YL Peng","year":"2024","unstructured":"Peng YL, et al. Effects of bile acids on the growth, composition and metabolism of gut bacteria. NPJ Biofilms Microbiomes. 2024;10(1):112.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"3","key":"5187_CR22","first-page":"291","volume":"14","author":"H Dong","year":"2025","unstructured":"Dong H, et al. Imbalance of bile acids metabolism mediated by gut microbiota contributed to metabolic disorders in diabetic model mice. Biology (Basel). 2025;14(3):291.","journal-title":"Biology (Basel)"},{"issue":"6","key":"5187_CR23","doi-asserted-by":"publisher","first-page":"2145","DOI":"10.1038\/s41390-024-03596-4","volume":"97","author":"HD de Vries","year":"2025","unstructured":"de Vries HD, et al. Elevated plasma bile acids coincide with cardiac stress and inflammation in young Cyp2c70(-\/-) mice. Pediatr Res. 2025;97(6):2145\u201352.","journal-title":"Pediatr Res"},{"issue":"2","key":"5187_CR24","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1007\/s40620-024-02185-2","volume":"38","author":"JH Gu","year":"2025","unstructured":"Gu JH, et al. Deoxycholic acid and the risk of death and cardiovascular events among patients with advanced chronic kidney disease. J Nephrol. 2025;38(2):799\u2013801.","journal-title":"J Nephrol"},{"issue":"1","key":"5187_CR25","doi-asserted-by":"publisher","first-page":"100387","DOI":"10.1016\/j.xkme.2021.09.004","volume":"4","author":"R Frazier","year":"2022","unstructured":"Frazier R, et al. Deoxycholic Acid and Risks of Cardiovascular Events, ESKD, and Mortality in CKD: The CRIC Study. Kidney Med. 2022;4(1):100387.","journal-title":"Kidney Med"},{"issue":"1","key":"5187_CR26","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1053\/j.jrn.2025.07.012","volume":"36","author":"B Mafrici","year":"2026","unstructured":"Mafrici B, et al. Amino acid and protein losses in adult patients receiving maintenance dialysis: A literature review. J Ren Nutr. 2026;36(1):30\u201348.","journal-title":"J Ren Nutr"},{"key":"5187_CR27","doi-asserted-by":"crossref","unstructured":"Li R, et al. Targeted metabolomics study of serum bile acid profile in patients with end-stage renal disease undergoinghemodialysis. PeerJ. 2019;7:e7145.","DOI":"10.7717\/peerj.7145"},{"issue":"8","key":"5187_CR28","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/j.cmet.2021.06.012","volume":"33","author":"BL Clifford","year":"2021","unstructured":"Clifford BL, et al. FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption. Cell Metab. 2021;33(8):1671\u2013e16844.","journal-title":"Cell Metab"},{"issue":"1","key":"5187_CR29","doi-asserted-by":"publisher","first-page":"p112","DOI":"10.1038\/s41522-024-00566-w","volume":"10","author":"YL Peng","year":"2024","unstructured":"Peng YL, et al. Effects of bile acids on the growth, composition and metabolism of gut bacteria. NPJ Biofilms Microbiomes. 2024;10(1):p112.","journal-title":"NPJ Biofilms Microbiomes"},{"issue":"4","key":"5187_CR30","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1097\/HEP.0000000000000611","volume":"79","author":"Y Huang","year":"2024","unstructured":"Huang Y, et al. Bile acid-induced IRF3 phosphorylation mediates cell death, inflammatory responses, and fibrosis in cholestasis-induced liver and kidney injury via regulation of ZBP1. Hepatology. 2024;79(4):752\u201367.","journal-title":"Hepatology"},{"issue":"2","key":"5187_CR31","doi-asserted-by":"publisher","first-page":"129","DOI":"10.3164\/jcbn.13-46","volume":"54","author":"T Adachi","year":"2014","unstructured":"Adachi T, et al. The involvement of endoplasmic reticulum stress in bile acid-induced hepatocellular injury. J Clin Biochem Nutr. 2014;54(2):129\u201335.","journal-title":"J Clin Biochem Nutr"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-026-05187-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05187-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-026-05187-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T02:37:53Z","timestamp":1791254273000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12882-026-05187-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,10]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5187"],"URL":"https:\/\/doi.org\/10.1186\/s12882-026-05187-3","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,10]]},"assertion":[{"value":"24 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Peking University Third Hospital (No. 096\u2009\u2212\u200903). The study procedure was conducted in accordance with the principles laid down by the Declaration of Helsinki. Informed consent was waived by IRB given the study was a retrospective, non-interventional design and using a de-identified dataset.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"587"}}